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Abstract 
Objectives: To investigate associations of long-term nutrient intake, physical activity and obesity 
with later cognitive function among the participants in the Finnish Diabetes Prevention Study, in 
which a lifestyle intervention was successful in diabetes prevention. 
Design: An active lifestyle intervention phase during middle age (mean duration 4 years) and 
extended follow-up (additional 9 years) with annual lifestyle measurements, followed by an 
ancillary cognition assessment. 
Setting: 5 research centers in Finland 
Participants: Of the 522 middle-aged, overweight participants with impaired glucose tolerance 
recruited to the study, 364 (70%) participated in the cognition assessment (mean age 68 years). 
 Measurements: A cognitive assessment was executed with the CERAD test battery and the Trail 
Making Test A on average 13 years after baseline. Lifestyle measurements included annual 
clinical measurements, food records, and exercise questionnaires during both the intervention 
and follow-up phase.   
Results: Lower intake of total fat (p=0.021) and saturated fatty acids (p=0.010), and frequent 
physical activity (p=0.040) during the whole study period were associated with better cognitive 
performance. Higher BMI (p=0.012) and waist circumference (p=0.012) were also associated 
with worse performance, but weight reduction prior to the cognition assessment predicted worse 
performance as well (decrease vs. increase, p=0.008 for BMI and p=0.002 for waist).  
Conclusions: Long-term dietary fat intake, BMI, and waist circumference have an inverse 
association with cognitive function in later life among people with IGT. However, decreases in 
BMI and waist prior to cognitive assessment are associated with worse cognitive performance, 
which could be explained by reverse causality.  
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Introduction 
 
Type 2 diabetes (T2D) is associated with cognitive decline and an increased risk for dementia in 
many studies (1), and cognitive decline and diabetes share several risk and protective factors. 
Recent meta-analyses show that adherence to the Mediterranean Diet (2) and physical activity 
(3) are associated with lower risk, and midlife obesity with an increased risk of dementia and 
cognitive decline (4). So far the evidence of the importance of lifestyles in cognitive decline 
comes mainly from observational studies. One lifestyle trial with cognition as a secondary 
outcome suggests better cognitive functions with the Mediterranean diet (5), but there are very 
few studies investigating long-term lifestyle changes and cognitive function in a controlled study 
design. 
 
The Finnish Diabetes Prevention Study (DPS) showed that T2D risk can be decreased by 58% 
with a lifestyle intervention (6). Better results were achieved with increasing number of lifestyle 
goals achieved. Due to shared risk factors we hypothesized that these lifestyle changes could be 
protective against cognitive decline, and completed ancillary cognitive assessment for the DPS 
participants on average 13 years after the study baseline. Intention to treat analyses showed no 
difference between the lifestyle intervention group and the control group in cognitive 
performance (Luchsinger et al, 2015, unpublished results). However, the association between 
particular lifestyles and cognitive performance were not examined. The aim of this secondary 
analysis is to investigate how lifestyle factors and changes in them from midlife to older age are 
associated with later cognitive performance. Specifically, we studied cognitive function in 
relation with dietary fat and fiber intake, weight, waist circumference and physical activity, the 
original targets of DPS lifestyle intervention, measured over a 13-year period.  
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Methods 
 
Subjects and setting 
This study was a sub-study to the DPS which has been described in detail previously (7). In 
brief, the DPS was a randomized, controlled, multi-center lifestyle intervention study aiming at 
type 2 diabetes prevention in a high-risk population (ClinicalsTrials.govNCT00518167). 
Participants were middle-aged (mean 55 years at randomization, range 40 to 65 years), 
overweight or obese (BMI > 25 kg/m
2
), and had impaired glucose tolerance (IGT) at baseline. 
The intervention group (n=265) received frequent individualized dietary, physical activity, and 
weight reduction counseling by the study nutritionist at 7 face-to-face counselling sessions 
during the first intervention year and every 3 months thereafter until the end of the intervention 
phase or diagnosis of diabetes. Voluntary free-of-charge supervised exercise sessions in the gym 
were also offered to the intervention group participants.  The control group (n=257) received 
only general health advice at baseline. The intervention phase was originally planned to continue 
for 6 years for each participant, but was prematurely discontinued based on the interim analyses 
showing a strong benefit in the lifestyle intervention group. Consequently, the average duration 
of the intervention phase was 4 years (range 1-6 years). The active intervention was followed by 
post-intervention follow-up phase with annual examinations. Cognition sub-study was initiated 
in 2009, on average 9 years after the end of the intervention phase (13 year after the 
randomization). The DPS study protocol was originally approved by the ethics committee of the 
National Public Health Institute in Helsinki, and the North Ostrobothnia Hospital District 
approved the follow-up study and the cognition study. All participants gave written informed 
consent at baseline, at the beginning of the follow-up, and prior to the cognitive assessments. 
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Clinical Measurements 
Baseline and annual examinations comprised 2-hour oral glucose tolerance test (OGTT), a 
medical history, and a physical examination with measurements of height (without shoes), 
weight (in light indoor clothes), waist circumference (midway between the lowest rib and iliac 
crest to the nearest 1 mm) and systolic and diastolic blood pressure (two measurements with a 
standard sphygmomanometer in sitting position, using the right arm, after 10 minutes of rest). 
BMI was calculated dividing body weight (kg) with the squared height (m
2
); for each person, the 
height measured at baseline was used for all time points. Average BMI (kg/m
2
) and waist 
circumference (cm) based on all available measurements during the study period were 
calculated. The Apolipoprotein E (APOE) genotypes were analysed using the polymerase chain 
reaction (PCR) with slight modifications, as described elsewhere (8).  
 
Lifestyle assessment 
A 3-day food record was completed and analysed at baseline, three times during the active 
intervention phase (years 1, 2, and 3), and twice during the follow-up. Recording was facilitated 
with a picture booklet, and completed records were checked by the study nutritionist. Nutrient 
intakes were calculated using a dietary analysis program and database developed in the Finnish 
National Public Health Institute (9). Average daily intakes of energy from total fat (E%), energy 
from saturated fat (SFA; E%) and dietary fiber (g) were calculated at baseline (intakes 
representing the time before the DPS) and averaged over the combined intervention and follow-
up phase (intakes representing the time during the DPS). Changes in nutrient intakes were 
calculated by subtracting the baseline value from the averaged value. 
 
Physical activity was self-reported. Participants reported their usual weekly frequency of 
physical activity with a four-category question, which was used to determine achievement of the 
exercise goal. They additionally filled in the validated Kuopio Ischemic Heart Disease (KIHD) 
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risk factor study questionnaire (10) to assess annual leisure-time physical activity (LTPA) in 
more detail. Mean weekly amount of moderate-to-vigorous LTPA (hours) was calculated 
annually and averaged over the whole study period. 
 
Lifestyle goals 
The five main goals of the DPS lifestyle intervention were weight reduction of 5% or more; less 
than 30% of the energy from fat; less than 10% of the energy from SFA; fiber intake of 
15g/1000 kcal (3.6 MJ) or more; and moderate intensity physical activity 30 min/day or more in 
average. Achievement of the dietary goals was determined based on mean intake during the 
intervention phase. Percentual weight change from baseline was defined at year 3, as well as 
physical activity response, using the last observation carried forward to replace missing values.  
 
Cognitive assessment 
The cognitive assessment was conducted twice: in 2009, on average 13 years after the DPS 
baseline, and again in 2011. All eligible participants in both former intervention and control 
groups (excluding those who had withdrawn from the study or died) were mailed an invitation 
letter to participate. Cognitive function was assessed by trained study nurses using the 
Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) (11) neuropsychological 
test battery (standardized Finnish translation) which is a sensitive measure for cognitive changes 
observed in Alzheimer’s disease, and Trail Making Test A (TMT) (letters) that measures 
visuomotor speed/ executive function (12). All participants with at least one cognitive 
assessment (n=364 for CERAD, n=362 for TMT) were included using the first available 
observation for each.  
 
The Finnish CERAD Battery is composed of 1) Verbal fluency (animals) 2) Modified Boston 
Naming test (15 words) 3) Mini-Mental State Exam 4) Word List Memory (ten words, three 
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trials) 5) Constructional praxis 6) Word List Recall (delayed recall of the ten words) 7) Word 
List Recognition (recognition of the ten words out of 20 words) 8) Constructional praxis recall 
9) Clock drawing. We calculated the CERAD total score (CERAD-TS) to measure overall 
cognitive performance according to Chandler et al (13). The TMT was calculated as time in 
seconds without upper limit (longer time indicating worse performance).  
 
Weight and waist change profiles 
For BMI and waist circumference, separate mean values were calculated for the active 
intervention phase and for the follow-up phase. Weight change categories were determined first 
as weight loss vs. weight gain during the intervention phase; then as loss vs. gain from 
intervention to follow-up phase. Similar categorization was applied for waist circumference.  
Finally, change profiles for BMI and waist were defined as follows: 1) decrease (during 
intervention) + decrease (during follow-up); 2) decrease + increase; 3) increase + decrease; 4) 
increase + increase, respectively.  
 
Statistical Methods 
Baseline characteristics were compared using t-test or chi2-test as applicable. Linear regression 
modeling was applied in all cognition analyses. We first adjusted for age and education (Model 
A), with education being both a surrogate for socio-economic status and for cognitive reserve. In 
the second model (Model B) additional adjustments were made for sex, APOE ε4 carrier status, 
baseline smoking, baseline systolic blood pressure, and intervention allocation. Missing baseline 
systolic blood pressure values (n=2), education (n=1) and smoking (n=1) were replaced with 
values measured at year 1. APOE ε4 carrier status was coded as 1 for any APOE ε4 and 0 for 
none. For missing APOE information (n=10) replacement with value 0.5 was applied and 
variable was entered as continuous. 
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Cognitive scores were skewed to the right, and box-cox transformation (14) improved normality. 
Hence all regression analyses were conducted with transformed cognition scores. For the amount 
of physical activity, distribution was skewed to the left and square-root transformation was 
applied. The transformations did not change results markedly, and we present the regression 
estimates using non-transformed models to facilitate interpretation. All p-values presented are 
based on models using box-cox transformation (and square-root-transformation, where 
applicable). One influential outlier in the CERAD-TS, scoring 38 points, was removed from the 
final analysis, although keeping the outlier in the model would not have changed the presented 
results. 
 
First, the compliance to the original DPS lifestyle intervention goals was analysed for the 
intervention phase and a success score indicating the total amount of goals was calculated. 
Second, linear models were run to investigate the linear association between cognitive 
performance and general level of the same lifestyle factors and changes in them, using data from 
all available years. Furthermore, weight change profiles were analysed as factor variables.  
 
We have previously reported that there were no differences in cognition between the former 
intervention and control groups in cognitive performance (Luchsinger et al, 2015, unpublished 
results), and therefore all analyses in this paper were performed for the whole group combined, 
adjusting for the intervention allocation. 
 
Analyses were conducted with STATA for Windows, release 11.2 (StataCorp LP, TX). p-value 
<0.05 was considered statistically significant. 
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Results 
 
Characteristics 
The cognition study included 364 participants (70% of the original DPS cohort). The participants 
had lower systolic blood pressure at baseline and during the study period, but there were no 
other differences compared with the non-participants (Table 1). The mean age was 55.1 ± 6.8 
years at baseline and 68.3 ± 6.8 years at cognition assessment. The cognition was assessed on 
average 13 years after the baseline visit (range 11 to 18 years, due to lengthy recruitment period) 
and the average time between the last lifestyle measurement and the cognition assessment was 4 
years for dietary variables and 2 years for weight and physical activity variables. The median 
number of measurements was for dietary intake 5 (range 1 to 5); for physical activity 9 (range 1 
to 12); and for BMI and waist circumference 10 (range 2 to 12). Lifestyle factors at baseline or 
during the study did not differ between participants and non-participants of the cognition study 
(results not shown). 
 
Achievement of lifestyle goals  
After three years of the intervention, 86% of the cognition study participants achieved at least 
one lifestyle goal, but only 3% achieved all five goals (n=9). Achievement of each of the goals 
was more common among the intervention group (χ 2-test, p < 0.05 for all). Achievement of the 
fat goal during the intervention phase was associated with better performance in the CERAD-TS, 
but other goals showed non-significant associations (Table 2). Higher number of goals achieved 
i.e. the high success score predicted better CERAD-TS (p for trend 0.012). No association with 
the TMT was detected.  
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Table 1. Characteristics of the DPS cohort 
 Cognition study 
participants  
(n=364) 
Non-
participants 
 (n=158) 
p -value 
Age , years    
At baseline 55.1±6.8 55.3±7.8 0.793 
Mean age during the study 61.1±6.7 60.2±7.9 0.188 
At the cognition study 68.3±6.7   
High education, n (%) 
a
 122 (34%) 50 (32%) 0.686 
Women, n (%) 250 (69%) 100 (63%) 0.265 
Intervention group, n (%) 184 (51%) 81 (51%) 0.924 
APOE4 ε4 carriers , n (%) 118 (33%) 46 (34%) 0.915 
Diagnosed with diabetes, n (%)    
At baseline 0 0  
After the intervention phase  70 (19%) 46 (29%) 0.016 
At the cognition study 168 (46%) 68 (43%) 0.566 
Fasting glucose, mmol/l    
At baseline 6.1±0.7 6.2±0.8 0.080 
Mean during the study 6.4±0.9 6.5±0.9 0.140 
Systolic BP, mmHg    
At baseline 136.8±17.2 140.9±18.4 0.017 
Mean during the study  136.1±14.0 139.6±14.8 0.011 
Cognition scores    
CERAD Total Score 82.0±9.3   
TMT-A 48.6±19.6   
Data are mean ±SD if not specified otherwise.
a
 At baseline 
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Table 2. Achievement of the DPS goals at year 3 and later cognition scores. 
 
 CERAD  
Total Score TMT-A 
Fat goal n 
  Not achieved (≥30 E%) 272  81.7 (80.7–82.6) 49.1 (46.9–51.3) 
Goal achieved  (< 30 E%) 88 83.5 (81.9–85.2) 47.1 (43.2–50.9) 
p (model A 
a
)  0.046 0.374 
p (model B 
b
)
  0.013 0.207 
SFA goal   
 Not achieved (≥10 E%) 330 82.0 (81.2–82.9) 48.5 (46.5–50.5) 
Goal achieved (<10 E%) 30 83.4 (80.6–86.3) 49.4 (42.9–56.0) 
p (model A 
a
)  0.313 0.351 
p (model B 
b
)  0.161 0.674 
Fiber goal  
  Not achieved (<15 g/100 kcal) 253 81.8 (80.8–82.7) 48.7 (46.4–51.0) 
Goal achieved (≥15 g/100 kcal) 107 83.0 (81.5–84.5) 48.3 (44.7–51.8) 
p (model A 
a
)  0.218 0.767 
p (model B 
b
)  0.151 0.350 
Weight loss goal  
  Not achieved (<5% weight loss) 257 81.9 (80.9–82.9) 49.2 (47.0–51.5) 
Goal achieved (≥5% weight loss 
or weight gain) 
107 
82.5 (81.0–84.0) 47.0 (43.6–50.5) 
p (model A 
a
)  0.398 0.068 
p (model B 
b
)  0.341 0.090 
Exercise goal   
 Not achieved  
(<4 hours per week ) 
87 
80.4 (78.7–82.1) 49.3 (45.4–53.2) 
Goal achieved 
 (≥4 hours per week) 
277 
82.6 (81.6–83.5) 48.3 (46.2–50.5) 
p (model A 
a
)  0.081 0.641 
p (model B 
b
)  0.071 0.875 
Success score (total amount of goals achieved) 
0  50 81.7 (79.5–83.9) 47.3 (42.1–52.4) 
1  144 81.6 (80.3–82.9) 49.9 (46.9–52.9) 
2  79 81.6 (79.9–83.4) 49.2 (45.1–53.3) 
3  50 82.8 (80.6–85.0) 46.9 (41.7–52.0) 
4 or 5 37 85.0 (82.4–87.5) 46.3 (40.4–52.3) 
p (trend, model A 
a
)  0.039 0.332 
p (trend, model B 
b
)  0.014 0.299 
Data are presented as adjusted mean (95% CI), adjusted for age and education. Better performance is indicated by 
higher CERAD-TS and shorter time in TMT.  
 
a 
Model A with box-cox transformed cognition scores, adjusted for age and education. 
 b
 Model B with box-cox transformed cognition scores, adjusted additionally for sex, APOE ε4 carriers status, and 
smoking status, systolic blood pressure, and intervention allocation.
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Lifestyle factors at baseline and lifestyle change during the study  
Neither diet nor physical activity at baseline was related to the cognitive performance (Table 3).  
Lower intake of total fat and SFA during the whole study period, as well as greater reduction in 
either one predicted better performance in CERAD-TS. Lower BMI or waist circumference at 
baseline and during the study was associated with better CERAD-TS. In addition, greater 
amount of moderate-to-vigorous physical activity during study was associated with better 
CERAD-TS. These results remained virtually unchanged when excluding those with less than 3 
lifestyle measurements (n=2–37 depending on the variable), or those with no data from the 
follow-up phase (n=7–77). However, the association between physical activity and CERAD-TS 
became non-significant by both exclusions (results not shown). 
 
Weight change profiles 
We found no differences in cognition between participants with weight loss vs. those with 
weight gain during intervention phase, whereas weight loss between the intervention and follow-
up phases predicted poorer performance in CERAD-TS (p=0.008 with full adjustment). Weight 
loss during the intervention followed by weight gain thereafter (profile “D-I”) predicted 
significantly better CERAD-TS compared with any other weight profile (Figure 1). Other groups 
did not differ from each other. The group with decreased waist circumference from baseline to 
the intervention phase had better performance in CERAD-TS than those with increased waistline 
(p=0.007, fully adjusted model), whereas those with decrease from the intervention to the 
follow-up phase performed worse (p=0.004). The waist change profile with decrease during the 
intervention and increase thereafter (profile “D-I”) was significantly advantageous in CERAD-
TS (Figure 2). The TMT results were non-associated with weight or waist changes (data not 
shown). 
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Table 3. Mean level of the lifestyle factors during the study and their mean change in association with later cognitive performance.  
Lifestyle factors and  
their mean levels during the study Linear associations with the cognition 
 
 CERAD TOTAL SCORE TMT-A 
 
mean±SD b (95% CI) p-value b (95% CI) p-value 
FAT INTAKE (E%)        
At baseline 36.6±6.6 0.00 (-0.13–0.13) 0.931 -0.04 (-0.34–0.25) 0.385 
Mean level during the study 33.1±4.7 -0.24 (-0.43– -0.04) 0.021 0.31 (-0.14–0.75) 0.228 
Mean change -3.5±6.7 -0.27 (-0.47– -0.06) 0.013 0.37 (-0.10–0.85) 0.106 
SFA INTAKE (E%)  
      At baseline 16.6±4.2 -0.09 (-0.30–0.12) 0.472 0.10 (-0.37–0.57) 0.836 
Mean level during the study 13.5±2.9 -0.41 (-0.73– -0.09) 0.010 0.65 (-0.08–1.38) 0.061 
Mean change -3.1±4.1 -0.41 (-0.75– -0.07) 0.014 0.67 (-0.11–1.45) 0.039 
FIBER INTAKE (g/1000 kcal)  
      At baseline 11.7±4.0 0.00 (-0.22–0.22) 0.780 0.35 (-0.15–0.84) 0.032 
Mean level during the study 13.3±3.5 0.10 (-0.16–0.36) 0.457 0.11 (-0.49–0.71) 0.627 
Mean change 1.6±3.7 0.13 (-0.17–0.43) 0.313 -0.13 (-0.82–0.56) 0.519 
Moderate-to vigorous LTPA (h/week)  
      At baseline 2.7±3.1 0.11 (-0.18–0.39) 0.127 -0.20 (-0.85–0.45) 0.186 
Mean level during the study 3.4±2.7 0.26 (-0.05–0.57) 0.040 -0.19 (-0.91–0.52) 0.538 
Mean change 0.7±2.4 0.25 (-0.11–0.60) 0.170 -0.13 (-0.95–0.69) 0.949 
BMI (kg/m2)  
      At baseline 31.2±4.5 -0.20 (-0.39– -0.01) 0.041 0.02 (-0.41–0.45) 0.744 
Mean level during the study 30.8±4.7 -0.23 (-0.41– -0.04) 0.011 0.11 (-0.31–0.53) 0.308 
Mean change -0.5±1.5 -0.32 (-0.81–0.18) 0.090 0.70 (-0.44–1.84) 0.050 
WAIST (cm)  
      At baseline 101.3±11.0 -0.10 (-0.17– -0.02) 0.022 -0.01 (-0.19–0.17) 0.860 
Mean level during the study 100.5±11.5 -0.09 (-0.16– -0.02) 0.012 0.04 (-0.13–0.21) 0.389 
Mean change -0.7±4.6 -0.08 (-0.25–0.09) 0.191 0.25 (-0.14–0.64) 0.085 
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Cognition data are presented as unstandardized regression coefficient (95% CI) representing change in cognitive scores per one unit increase in lifestyle factors.  Regression coefficients 
from model using non-transformed cognitions score and p values from models using box-cox transformed cognition scores.  Better performance is indicated by higher CERAD-TS and 
shorter time in TMT. Model adjusted for age, education, sex, APOE ε4 carrier status and smoking status, systolic blood pressure, and BMI at baseline.  
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Figure 1. CERAD-TS according to the direction of weight change in different study phases 
(weight change profile).  
 
Groups are D-D) decrease (at intervention) + decrease (at follow-up) D-I) decrease + increase; I-D) increase + 
decrease; I-I) increase + increase. Data are presented as adjusted mean with error bars indicating 95% CI. Group 2 
as a reference group; model adjusted for age, education, sex, APOE ε4 carrier status and smoking status, systolic 
blood pressure, and BMI at baseline. * p<0.05 ** p<0.01. 
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Figure 2. CERAD-TS (adjusted mean and 95% CI) according to the direction of change in 
waist circumference in different study phases (waist change profile). 
 
Groups are D-D) decrease (at intervention) + decrease (at follow-up) D-I) decrease + increase; I-D) increase + 
decrease; I-I) increase + increase. Data are presented as adjusted mean with error bars indicating 95% CI. Group 2 
as a reference group; model adjusted for age, education, sex, APOE ε4 carrier status and smoking status, systolic 
blood pressure, and BMI at baseline. * p<0.05 
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Discussion 
 
Our results show that a long-term healthier lifestyle and positive lifestyle changes are associated 
with better cognition later in life among a population with IGT at baseline. Obesity measures 
appeared to have a two-sided relationship as lower BMI and waist circumference at baseline and 
during the intervention phase were associated with better cognitive function, whereas declining 
weight prior to cognitive assessment predicted poorer cognition, possibly due to reverse 
causality. 
 
Dietary intervention studies focusing on cognitive outcomes are scarce. The DASH-diet, 
originally developed to decrease hypertension, improved cognitive function (15) over 4 months, 
but so far no long-term dietary intervention studies investigating cognitive changes are available. 
One cardiovascular disease prevention trial suggested that Mediterranean diet was beneficial for 
cognition after 6 years of intervention (5), but unfortunately this study lacks the baseline 
cognition assessment as does our study. In the DPS, cognitive performance did not differ 
between the intervention and control groups despite the difference in diabetes incidence. 
Lifestyle changes reported in this paper may partially explain the lack of differences; both 
groups actually improved their lifestyle during the study, and this may have diluted the 
differences between the groups. The control group actually also received health advice and 
monitoring, although with less intensity than the intervention group. 
 
Our results showing that both total fat and SFA are associated with worse cognitive function are 
in line with previous epidemiological studies concerning SFA (16-18), although not all studies 
confirm this association (19). Total fat intake has been associated with increased risk for AD 
(20, 21), and total fat intake from milk and spreads with poorer cognitive function (16). Other 
fatty acids such as higher intake of monounsaturated fatty acids (18) or lower ratio of 
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polyunsaturated fatty acids to SFA (17) have also been associated with better cognitive function 
in these studies. To our knowledge, this is the first study linking reduction in total fat/SFA intake 
to better cognitive function. We only focused on fats that were emphasized in the original DPS 
intervention, which is one of the limitations in our study. Some studies also suggest a positive 
association between fiber intake and cognitive function (22, 23), although we found no evidence 
of such relationship. Fiber intake in Finland is relatively high, and was additionally emphasized 
in the lifestyle intervention, which may result in less variability between the participants.  
 
Physical activity has been linked to less cognitive decline and lower risk of AD (24), and lower 
risk of mild cognitive impairment (25), but associations were weaker among diabetic 
participants (26). The association we found was relatively weak and diminished after excluding 
those with only few measurements. There are only few studies investigating changes in physical 
activity in relation to cognition or dementia. One study focusing on physical activity (27) and 
other on leisure and social activities (28) both showed that remaining active over long time or 
becoming active was linked to lower risk of dementia later on. Short-term clinical trials (6 
months) have shown some benefits among those with mild cognitive impairment (29, 30) and 
also among participants with glucose intolerance (31).  
 
Our findings about associations between higher BMI or waist circumference and worse cognitive 
performance are in agreement with previous prospective studies (32, 33), but findings regarding 
weight loss are more controversial. Stable weight has been suggested the most beneficial (34), 
and weight loss 5 years prior to the cognitive assessment has predicted poorer results (35), in 
accordance with our study. However, we also found decline in waistline to predict poorer 
cognition, whereas other studies found no evidence for a relationship between waist change and 
cognitive function (34, 35).  
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Interestingly, among our overweight participants, a combination of weight loss during the 
intervention phase but no weight loss thereafter appeared the most beneficial. Weight loss during 
the intervention was presumably intentional, whereas the weight change thereafter may be 
confounded by unintentional weight loss, which can be a sign of pre-clinical AD (36). A small 
pilot study indicated that intentional weight loss would be beneficial for cognitive function (37), 
but another trial aiming to weight loss among diabetes patients had no effect on cognition 
assessed cross-sectionally later in life (38). Weight loss close to cognitive assessment could be a 
marker, rather than a cause, of underlying cognitive or other health problems. Furthermore, our 
participants were older during the follow-up and the associations between traditional risk factors 
and cognitive functions may change with age due to reverse causality. Several studies have 
demonstrated a decline in weight, blood pressure or cholesterol prior to diagnosis of dementia 
(39), and for example presence of the metabolic syndrome has actually been linked to less 
cognitive decline in old age (40). 
 
Among the strengths of our study are the repeated lifestyle measurements that were carried out 
frequently and using relatively precise methods such as food diaries and detailed KIHD 
questionnaire during a long period of time. We were also able to assess changes in lifestyle over 
a long time which is not usually possible. Most of the previous studies use only one single 
dietary assessment. Averaging several measurements gives a more reliable estimate for dietary 
intake over a long time. For obesity measures we had even more frequent time series and thus 
were able to see different patterns in weight changes.  
 
There are also limitations that need to be addressed. Most importantly, the cognitive 
measurement was conducted only at the end of the study and no data on baseline cognition were 
collected. Therefore it is possible that those who achieved and maintained healthier lifestyle 
during the study may have had better cognition to start with. However, we had a relatively young 
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group of participants, with a relatively high level of cognitive function even at the end of our 
follow-up study. Due to the long follow-up there were also drop-outs, and only 70% of the 
original cohort participated in the cognition study. Those with cognitive or other health problems 
may have been unable to participate, even though the baseline characteristics of the cognition 
cohort did not differ markedly from the entire cohort. Our analyses were focused on the 
lifestyles that were subject to the original intervention of the DPS, whereas other lifestyle factors 
could also have affected cognitive function along with the studied factors. Furthermore, we were 
not able to distinguish intentional and unintentional weight reduction, which, like said before, 
could have opposite effects on cognition. Lack of statistical power may also have an impact on 
the analyses between cognition and separate goals, as not so many participants achieved the 
lifestyle goals. Furthermore, all our participants had an increased risk of diabetes at baseline, and 
almost half of them developed diabetes during the study, and therefore the results of our study 
are best generalizable to persons with IGT.  
  
Lifestyle interventions have become standard of care for persons with IGT, and our results 
highlight the potential importance of lifestyle factors in maintaining good cognitive functions in 
this population also in older age. Furthermore, the DPS intervention goals indicate the benefits 
with a multi-goal-approach: cognitive performance improved with the total amount of goals 
achieved. Multidomain interventions have been suggested to be best intervention strategy also to 
support healthy aging (41). However, due the previously reported lack of difference between the 
intervention and control groups it remains unclear whether a lifestyle intervention in mid-life is 
efficient enough to alter cognitive functions later in life as it has been shown to do with 
prevention of diabetes (42). The effect of intentional and unintentional weight loss, and also the 
effect of changes in diet and exercise in different time points in life on cognition deserves more 
investigation in future studies. Lifestyle intervention trials with cognitive functions as primary 
21 
 
 
outcomes, cognition biomarkers, and long follow-up are necessary to confirm the potential 
benefits of lifestyle interventions on cognition.  
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